Cefotaxime
Back to searchMolecule Structure
Scientific Name
Cefotaxime
Description of the Drug
Cefotaxime is a third generation cephalosporin used to treat susceptible Gram negative and Gram positive bacterial infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00493
http://www.drugbank.ca/drugs/DB00493
Brand Name(s)
Not Available
Company Owner(s)
B Braun Medical Inc, Validus Pharmaceuticals Llc, Hospira Inc, Sanofi Aventis Us Llc, Fresenius Kabi Usa Llc, Wockhardt Ltd, Lupin Ltd, Cephazone Pharma Llc, Hikma Farmaceutica Lda, Aurobindo Pharma Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bacterial penicillin-binding protein | PROTEIN FAMILY | INHIBITOR | CHEMBL2354204 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL3731931 | ||
| Human Metabolome Database | HMDB0014636 | ||
| WDI | CEFOTAXIM | ||
| DrugBank | DB00493 | ||
| PubChem: Thomson Pharma | 14857885 | 14808825 | |
| PubChem | 5742673 | ||
| Nikkaji | J18.743G | ||
| PDBe | CE3 | ||
| BindingDB | 50482777 | ||
| DrugCentral | 546 | ||
| ChemicalBook | CB6511698 | ||
| Guide to Pharmacology | 10893 | ||
| GSRS | cb25e744-b263-464a-aa39-800cfa0650c3 | ||
| rxnorm | CEFOTAXIME | CEFOTAXIME SODIUM | CLAFORAN |
| KEGG Ligand | C06885 | ||
| ChEBI | 204928 | ||
| ZINC | ZINC000004468780 |
